Aspergillus endophthalmitis following orthotopic heart transplant.
Gregory
Maria Elena
ME
Weir
Clifford R
CR
Roberts
Fiona
F
Browne
Benjamin H
BH
D000038:Abscess / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D015353:Eye Enucleation; D015821:Eye Infections, Fungal / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D014822:Vitreous Body / Q000382:microbiology
D000935:Antifungal Agents; D007166:Immunosuppressive Agents